Ignite Creation Date:
2024-05-06 @ 2:47 AM
Last Modification Date:
2024-10-26 @ 11:23 AM
Study NCT ID:
NCT02129179
Status:
COMPLETED
Last Update Posted:
2018-04-05
First Post:
2014-04-30
Brief Title:
The Effect of Glucagon-Like Peptide-1 GLP-1 on Pulmonary Vascular Resistance PVR in Patients With Heart Failure
Sponsor:
Papworth Hospital NHS Foundation Trust
Organization:
Papworth Hospital NHS Foundation Trust
Study Overview
Official Title:
The Effect of Glucagon-Like Peptide-1 GLP-1 on Pulmonary Vascular Resistance PVR in Patients With Heart Failure
Status:
COMPLETED
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to assess the effect of glucagon-like peptide-1 on cardiac output and transpulmonary gradient in patients undergoing right heart catheterisation for clinical reasons
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None